 |
Davide Ruggero, PhD
Recent Publications |
Publications – 2009 |
 |
Feldman, M.E., B. Apsel, A. Uotila,
R. Loewith, Z.A. Knight, D. Ruggero, and K.M. Shokat, Active-site
inhibitors of mTOR target rapamycin-resistant outputs of
mTORC1 and mTORC2. PLoS Biol, 2009. 7(2): p. e38. |
| |
Publications – 2008 |
|
Barna, M., A. Pusic, O. Zollo, M.
Costa, N. Kondrashov, E. Rego, P.H. Rao, and D.
Ruggero,
Suppression of Myc oncogenic activity by ribosomal protein
haploinsufficiency. Nature, 2008. 456(7224): p. 971-5. |
| |
Publications – 2006 |
|
Rego, E.M., D.
Ruggero, C. Tribioli,
G. Cattoretti, S. Kogan, R.L. Redner, and P.P. Pandolfi,
Leukemia with distinct phenotypes in transgenic mice expressing
PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha. Oncogene,
2006. 25(13): p. 1974-9. |
|
Yoon, A., G. Peng, Y. Brandenburger,
O. Zollo, W. Xu, E. Rego, and D. Ruggero, Impaired control
of IRES-mediated translation in X-linked dyskeratosis congenita.
Science, 2006. 312(5775): p. 902-6.
|
| |
Publications – 2005 |
|
Kaplan, R.N., R.D. Riba, S. Zacharoulis,
A.H. Bramley, L. Vincent, C. Costa, D.D. MacDonald, D.K.
Jin, K. Shido, S.A. Kerns, Z. Zhu, D. Hicklin, Y. Wu, J.L.
Port, N. Altorki, E.R. Port, D. Ruggero, S.V. Shmelkov,
K.K. Jensen, S. Rafii, and D. Lyden, VEGFR1-positive haematopoietic
bone marrow progenitors initiate the pre-metastatic niche.
Nature, 2005. 438(7069): p. 820-7. |
|
Ruggero, D. and N. Sonenberg, The Akt
of translational control. Oncogene, 2005. 24(50): p. 7426-34. |
| |
return
to top
|
|
|
|
|
|
